BIOTE CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.39 USD | -0.14% |
|
-1.07% | +49.60% |
| Jul. 01 | Biote Corp.(NasdaqGM:BTMD) dropped from Russell 2000 Value-Defensive Index | CI |
| Jul. 01 | Biote Corp.(NasdaqGM:BTMD) dropped from Russell 2000 Growth-Defensive Index | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | - | 40.51 | 175.5 | 212.3 | - | - |
| Enterprise Value (EV) 1 | - | 81.71 | 201.4 | 286.8 | 270.2 | 212.3 |
| P/E ratio | 0.29 x | -31.1 x | 38 x | 27.4 x | 11.3 x | 9.99 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | 0.25 x | 0.95 x | 1.05 x | 0.91 x | 0.76 x |
| EV / Revenue | - | 0.5 x | 1.09 x | 1.42 x | 1.15 x | 0.76 x |
| EV / EBITDA | - | 1.63 x | 3.64 x | 4.67 x | 3.71 x | 2.47 x |
| EV / FCF | - | 2.73 x | 8.33 x | 8.22 x | 6.08 x | 4.96 x |
| FCF Yield | - | 36.6% | 12% | 12.2% | 16.4% | 20.2% |
| Price to Book | - | - | -5.76 x | -4.93 x | -7.14 x | 9.85 x |
| Nbr of stocks (in thousands) | - | 10,860 | 35,528 | 28,734 | - | - |
| Reference price 2 | 9.800 | 3.730 | 4.940 | 7.390 | 7.390 | 7.390 |
| Announcement Date | 5/5/22 | 3/28/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 165 | 185.4 | 202 | 234.3 | 277.8 |
| EBITDA 1 | - | 50.13 | 55.26 | 61.38 | 72.84 | 86.1 |
| EBIT 1 | - | -60.72 | 28.66 | 42.84 | 54.03 | 63.21 |
| Operating Margin | - | -36.81% | 15.46% | 21.2% | 23.06% | 22.75% |
| Earnings before Tax (EBT) 1 | - | 1.712 | -0.123 | 23.07 | 47.42 | 47.19 |
| Net income 1 | 32.62 | -0.969 | 3.316 | 12.31 | 27.46 | 25.28 |
| Net margin | - | -0.59% | 1.79% | 6.09% | 11.72% | 9.1% |
| EPS 2 | 33.29 | -0.1200 | 0.1300 | 0.2700 | 0.6567 | 0.7400 |
| Free Cash Flow 1 | - | 29.91 | 24.17 | 34.9 | 44.4 | 42.83 |
| FCF margin | - | 18.13% | 13.04% | 17.27% | 18.95% | 15.41% |
| FCF Conversion (EBITDA) | - | 59.67% | 43.74% | 56.86% | 60.95% | 49.74% |
| FCF Conversion (Net income) | - | - | 728.89% | 283.43% | 161.67% | 169.41% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/5/22 | 3/28/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 41.36 | 41.97 | 44.48 | 44.84 | 49.26 | 45.56 | 45.7 | 46.8 | 49.06 | 51.2 | 54.75 | 53.13 | 56.75 |
| EBITDA 1 | 13.15 | 12.24 | 13.12 | 13.11 | 14.54 | 14.04 | 13.57 | 14.16 | 14.35 | 15.61 | 17.3 | 15.68 | 17.64 |
| EBIT 1 | -85.6 | 7.815 | 7.303 | 7.881 | 7.669 | 7.599 | 5.508 | 10.43 | 9.119 | 10.69 | 12.3 | 12.66 | 14.48 |
| Operating Margin | -206.98% | 18.62% | 16.42% | 17.57% | 15.57% | 16.68% | 12.05% | 22.28% | 18.59% | 20.88% | 22.47% | 23.82% | 25.52% |
| Earnings before Tax (EBT) 1 | 40 | -6.112 | 13.24 | -20.8 | -12.17 | 23.52 | 9.334 | -3.324 | 7.164 | 8.709 | 10.51 | 11.21 | 13.09 |
| Net income 1 | 115.5 | -13.24 | 1.622 | -6.805 | -5.143 | 7.53 | 7.734 | -2.07 | 4.079 | 5.093 | 6.152 | 5.824 | 7.082 |
| Net margin | 279.16% | -31.54% | 3.65% | -15.18% | -10.44% | 16.53% | 16.92% | -4.42% | 8.31% | 9.95% | 11.24% | 10.96% | 12.48% |
| EPS 2 | 2.010 | -1.740 | 0.1800 | -0.3900 | -0.2500 | 0.2500 | 0.1800 | -0.0600 | 0.0867 | 0.0967 | 0.1300 | 0.1400 | 0.1750 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/9/22 | 11/14/22 | 3/28/23 | 5/9/23 | 8/10/23 | 11/7/23 | 3/12/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 41.2 | 25.9 | 74.5 | 57.8 | - |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0.8219 x | 0.4682 x | 1.214 x | 0.7937 x | - |
| Free Cash Flow 1 | - | 29.9 | 24.2 | 34.9 | 44.4 | 42.8 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | 2.48% | 11.5% | 24.8% | - |
| Assets 1 | - | - | 133.5 | 107.1 | 110.7 | - |
| Book Value Per Share 2 | - | - | -0.8600 | -1.500 | -1.040 | 0.7500 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | - | 2.71 | 9.05 | 4 | 4 |
| Capex / Sales | - | - | 1.46% | 4.48% | 1.71% | 1.44% |
| Announcement Date | 5/5/22 | 3/28/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
7.39
USD
Average target price
9.266
USD
Spread / Average Target
+25.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +49.60% | 212M | |
| +82.05% | 1.11B | |
| -75.62% | 283M | |
| -7.92% | 131M | |
| +8.70% | 58.33M |
- Stock Market
- Equities
- BTMD Stock
- Financials biote Corp.
